Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.
Journal:
Clinical neurology and neurosurgery
PMID:
40010238
Abstract
INTRODUCTION: Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.